New GenVec CEO eliminates jobs

GenVec's new CEO, Cynthia Collins, will restructure the company, eliminating about a third of its workforce. Collins, who joined GenVec in the spring, announced she will slash 23 jobs throughout the organization. She said cuts are necessary "to ensure that our costs are more closely aligned with our resources and business strategy." Release | FierceBiotech story

Suggested Articles

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.